Tasman Pharma Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for TASMAN PHARMA, and what generic alternatives to TASMAN PHARMA drugs are available?
TASMAN PHARMA has five approved drugs.
There is one US patent protecting TASMAN PHARMA drugs.
There are six patent family members on TASMAN PHARMA drugs in six countries and one supplementary protection certificate in one country.
Summary for Tasman Pharma
| International Patents: | 6 |
| US Patents: | 1 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Tasman Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tasman Pharma | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | OIL/DROPS;OTIC | 213264-001 | Feb 5, 2021 | AT | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Tasman Pharma | KETOCONAZOLE | ketoconazole | CREAM;TOPICAL | 215185-001 | Nov 17, 2021 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| Tasman Pharma | VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479-001 | Feb 6, 2013 | RX | Yes | Yes | 8,057,811 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Tasman Pharma | CLOTRIMAZOLE | clotrimazole | SOLUTION;TOPICAL | 212281-001 | Jul 25, 2019 | AT | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Tasman Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| New Zealand | 527142 | See Plans and Pricing |
| Spain | 2436213 | See Plans and Pricing |
| World Intellectual Property Organization (WIPO) | 2005007168 | See Plans and Pricing |
| Australia | 2004257556 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Tasman Pharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2233112 | 132014902285293 | Italy | See Plans and Pricing | PRODUCT NAME: FLUOCINOLONE ACETONIDE(ILUVIEN); AUTHORISATION NUMBER(S) AND DATE(S): 042616019, 20140530;PL27813/0001, 20120504 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
